Federal Circuit Review - Volume 3 | Issue 5 - May 2013


In This Issue:

• Patent Office Must Prove Prior Art Reference Is Enabling

• Complaint Was Adequate Despite Non-Infringing Possibilities

• FDA Approval Not Relevant to Obviousness Analysis

- Excerpt from Patent Office Must Prove Prior Art Reference Is Enabling:

In In Re Steve Morsa, Appeal No. 12-1609, the Federal Circuit affirmed the Board’s rejection of certain claims as obvious, vacated the Board’s rejection of certain claims as anticipated, and remanded for a proper enablement analysis.

Morsa filed several hundred claims directed to a benefits information database, two of which were rejected as anticipated by a short press release that announced the launch of an Internet-based benefit database product. Morsa appealed the anticipation rejection to the Board, arguing that the press release was not an enabling disclosure. The Board sustained the rejection and subsequently denied two requests for a rehearing on the issue of anticipation...

Please see full newsletter below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Allergan Inc, Allergan v Sandoz, FDA, Infringement, Obviousness, Patents, Prior Art, Time Warner

Published In: Civil Procedure Updates, Intellectual Property Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Knobbe Martens Olson & Bear LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »